insights_auto
Why is VRAX down 5,69%?
Dive Deeperchevron_right
VRAX:NASDAQ
Virax Biolabs Group Ltd
1,99 USD
arrow_downward
-5,69%(-0,12) 1D
1,78 USD
arrow_downward
-10,55% (-0,21)todayPre-market
Closed: 8-окт., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRAX...
Open
2,13 USD
High
2,13 USD
Low
1,93 USD
Mkt. cap
2,63 млн
Avg. vol.
149,66 миң
Volume
214,00
52-wk high
21,75 USD
52-wk low
1,83 USD
EPS
-12,64 USD
Beta
1,40
Shares outstanding
1,34 млн
No. of employees
26
Open
2,13 USD
High
2,13 USD
Low
1,93 USD
Mkt. cap
2,63 млн
Avg. vol.
149,66 миң
Volume
214,00
52-wk high
21,75 USD
52-wk low
1,83 USD
EPS
-12,64 USD
Beta
1,40
Shares outstanding
1,34 млн
No. of employees
26
News stories
From web sources and news partners
Barron's
·
6 мүнөт мурун
Small-Cap Stocks Could Be Ready to Rebound
The Motley Fool
·
8 мүнөт мурун
The U.S. Economy Just Delivered Bad News. History Says It Could Be Good News for the S&P 500.
TradingView
·
1 саат мурун
Why Are Nasdaq Futures Surging Premarket? SPCX, ASTS, AAPL, TMUS, VZ, NVDA, MU, LITE Stocks In Focus
Yahoo Finance
·
2 саат мурун
Scancell revs up for Nasdaq listing as cancer vaccine developer prepares phase III melanoma trial
About Virax Biolabs Group Ltd
CEO-
Employees26
Founded2013
HeadquartersЛондон, Ингленд, Улуу Британия
SectorHealth care provider
Websiteviraxbiolabs.com